SymThera Ltd.

A drug discovery company with a unique technology platform capable of identifying novel treatments for autoimmune and inflammatory diseases with unmet medical needs.

Biotechnology
Active
Ness-Ziona, Israel Founded 2006
Last updated 2026-09-01
Total raised
—
Stage
—
Founded
2006
Headcount
—
HQ
Ness-Ziona, Israel
Sector
Biotechnology

About

Our Approach. SymThera combines scientific insight with proprietary technology to rationally design drug leads that appropriately affect multiple targets with a single agent to provide a more robust impact on restoring health. SymThera's drug leads, biological peptides, address the immediate shortcomings of existing medication. SymThera believes that it occupies a unique niche in drug discovery by being the first company to exploit network theory to identify patterns of conserved functionality in groups of disease-associated proteins known to control disease-specific inflammation.

Offices

Ness-Ziona, Israel · HQ / main office

Q&A

What is SymThera Ltd.'s primary focus?
SymThera Ltd. is a drug discovery company focused on identifying novel treatments for autoimmune and inflammatory diseases with unmet medical needs.
When was SymThera Ltd. founded?
SymThera Ltd. was founded in 2006.
Where is SymThera Ltd. headquartered?
SymThera Ltd. is headquartered in Ness-Ziona, Israel.
What is SymThera Ltd.'s core technology?
SymThera Ltd. utilizes a proprietary drug discovery platform that combines scientific insight with technology to design drug leads affecting multiple targets with a single agent, specifically biological peptides.
Which diseases does SymThera Ltd. target?
SymThera Ltd. targets autoimmune diseases, inflammatory diseases, and metastatic cancer.
Who is a key founder of SymThera Ltd.?
Chai Ezerzer is a founder of SymThera Ltd. and serves as the Chief Science Officer.

Team · 5

Rose M. Sinicrope
President
Chai Ezerzer
Chief Science Officer
David A. Kennard
Director of International Operations (Consultant)
Jeffrey L. Balash
Chief Financial Officer (Consultant)
Michael J. Sinclair
Chairman of the Board of Directors

Sectors & technology

Primary sector
Biotechnology
Technologies
Target customers
Business model
Biopharmaceutical Development
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitesymthera.com

Identifiers & details

Legal nameSymthera, Inc.
Founded2006

Radar intelligence

Patents

EPO3

Web history (Wayback)

Domainsymthera.com